• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆游离循环 DNA 升高可能成为口腔癌的一个潜在标志物。

Increased Plasma Circulating Cell-Free DNA Could Be a Potential Marker for Oral Cancer.

机构信息

Department of Medical Research, MacKay Memorial Hospital, Taipei 10449, Taiwan.

Institute of Oral Biology, School of Dentistry, National Yang-Ming University, Department of Stomatology, Medical Education and Research, Veterans General Hospital, Taipei 11217, Taiwan.

出版信息

Int J Mol Sci. 2018 Oct 24;19(11):3303. doi: 10.3390/ijms19113303.

DOI:10.3390/ijms19113303
PMID:30352977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6274798/
Abstract

BACKGROUND

Oral squamous cell carcinoma (OSCC) is a disease that affects patients worldwide. DNA of dead cells is released into the blood stream and may be isolated from plasma or serum samples. This DNA is termed cell-free DNA (cfDNA). cfDNA is increased in several types of malignancies. We investigated if there was a correlation between cfDNA levels and the progression of OSCC.

METHODS

Using quantitative spectrometry, we measured plasma cfDNA in 121 patients with OSCC and 50 matched controls. Mann Whitney and Wilcoxon tests were used to compare differences among various clinical variants. Receiver operating characteristic (ROC) analysis was used to obtain levels suitable for the separation of the clinical subsets. Kaplan-Meier analysis was used to assess correlation with survival.

RESULTS

Plasma cfDNA was significantly elevated in patients with OSCC relative to controls. Plasma cfDNA levels correlated with larger tumor size, cervical lymph node metastasis and late stage. Higher plasma cfDNA levels were associated with a poor prognosis of OSCC, which is a new finding.

CONCLUSION

Plasma cfDNA could serve as a novel and easily accessible biomarker in OSCC, providing diagnostic and prognostic value.

摘要

背景

口腔鳞状细胞癌(OSCC)是一种影响全球患者的疾病。死亡细胞的 DNA 会释放到血液中,并可从血浆或血清样本中分离出来。这种 DNA 被称为游离 DNA(cfDNA)。cfDNA 在几种恶性肿瘤中增加。我们研究了 cfDNA 水平与 OSCC 进展之间是否存在相关性。

方法

使用定量光谱法,我们测量了 121 例 OSCC 患者和 50 例匹配对照者的血浆 cfDNA。Mann Whitney 和 Wilcoxon 检验用于比较各种临床变量之间的差异。接收者操作特征(ROC)分析用于获得适合分离临床亚组的水平。Kaplan-Meier 分析用于评估与生存的相关性。

结果

与对照组相比,OSCC 患者的血浆 cfDNA 明显升高。血浆 cfDNA 水平与更大的肿瘤大小、颈部淋巴结转移和晚期相关。较高的血浆 cfDNA 水平与 OSCC 的不良预后相关,这是一个新发现。

结论

血浆 cfDNA 可作为 OSCC 的一种新型且易于获取的生物标志物,提供诊断和预后价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ed/6274798/d2d3297d8e32/ijms-19-03303-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ed/6274798/9d3d8b0f00f2/ijms-19-03303-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ed/6274798/1fcfd866385b/ijms-19-03303-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ed/6274798/d2d3297d8e32/ijms-19-03303-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ed/6274798/9d3d8b0f00f2/ijms-19-03303-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ed/6274798/1fcfd866385b/ijms-19-03303-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ed/6274798/d2d3297d8e32/ijms-19-03303-g003.jpg

相似文献

1
Increased Plasma Circulating Cell-Free DNA Could Be a Potential Marker for Oral Cancer.血浆游离循环 DNA 升高可能成为口腔癌的一个潜在标志物。
Int J Mol Sci. 2018 Oct 24;19(11):3303. doi: 10.3390/ijms19113303.
2
Can quantifying free-circulating DNA be a diagnostic and prognostic marker in oral epithelial dysplasia and oral squamous cell carcinoma?游离循环DNA的定量能否作为口腔上皮发育异常和口腔鳞状细胞癌的诊断及预后标志物?
J Oral Maxillofac Surg. 2013 Feb;71(2):414-8. doi: 10.1016/j.joms.2012.04.039. Epub 2012 Jun 29.
3
Comparison of circulating DNA in malignant neoplasia from diverse locations: Investigating a diagnostic role.比较不同部位恶性肿瘤的循环 DNA:探索诊断作用。
Indian J Pathol Microbiol. 2022 Jan-Mar;65(1):93-99. doi: 10.4103/IJPM.IJPM_474_20.
4
Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.循环抗基质金属蛋白酶-7抗体可能是口腔鳞状细胞癌的潜在生物标志物。
J Oral Maxillofac Surg. 2016 Mar;74(3):650-7. doi: 10.1016/j.joms.2015.09.016. Epub 2015 Sep 26.
5
Quantification of circulating plasma cell free DNA fragments in patients with oral cancer and precancer.口腔癌及癌前病变患者循环血浆游离DNA片段的定量分析
Gulf J Oncolog. 2018 May;1(27):11-17.
6
Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.血清微小RNA-483-5p:口腔鳞状细胞癌患者一种新型的诊断和预后生物标志物。
Tumour Biol. 2016 Jan;37(1):447-53. doi: 10.1007/s13277-015-3514-z. Epub 2015 Jul 30.
7
Evaluation of saliva and plasma cytokine biomarkers in patients with oral squamous cell carcinoma.口腔鳞状细胞癌患者唾液和血浆细胞因子生物标志物的评估
Int J Oral Maxillofac Surg. 2018 Jun;47(6):699-707. doi: 10.1016/j.ijom.2017.09.016. Epub 2017 Nov 27.
8
Diagnostic and prognostic value of serum miR-99a expression in oral squamous cell carcinoma.血清 miR-99a 表达在口腔鳞状细胞癌中的诊断和预后价值。
Cancer Biomark. 2018;23(3):333-339. doi: 10.3233/CBM-181265.
9
Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma.血清Gas6升高是口腔鳞状细胞癌患者一种新的预后生物标志物。
PLoS One. 2015 Jul 24;10(7):e0133940. doi: 10.1371/journal.pone.0133940. eCollection 2015.
10
Increased serum placenta growth factor level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.血清胎盘生长因子水平升高与口腔鳞状细胞癌的进展、复发和不良预后显著相关。
Oral Oncol. 2012 May;48(5):424-8. doi: 10.1016/j.oraloncology.2011.12.007. Epub 2012 Jan 13.

引用本文的文献

1
Molecular and Genetic Pathogenesis of Oral Cancer: A Basis for Customized Diagnosis and Treatment.口腔癌的分子与遗传发病机制:定制化诊断与治疗的基础
Biology (Basel). 2025 Jul 10;14(7):842. doi: 10.3390/biology14070842.
2
Cell-Free DNA as a Prognostic Biomarker in Oral Carcinogenesis and Oral Squamous Cell Carcinoma: A Translational Perspective.游离DNA作为口腔癌发生和口腔鳞状细胞癌的预后生物标志物:转化医学视角
Cancers (Basel). 2025 Jul 16;17(14):2366. doi: 10.3390/cancers17142366.
3
Comparison of level of circulating tumor DNA between oral squamous cell carcinoma and healthy controls: a case control study.

本文引用的文献

1
Quantification of circulating plasma cell free DNA fragments in patients with oral cancer and precancer.口腔癌及癌前病变患者循环血浆游离DNA片段的定量分析
Gulf J Oncolog. 2018 May;1(27):11-17.
2
Cell-Free Circulating DNA Integrity Based on Peripheral Blood as a Biomarker for Diagnosis of Cancer: A Systematic Review.基于外周血游离循环 DNA 完整性的癌症诊断生物标志物:系统综述。
Cancer Epidemiol Biomarkers Prev. 2017 Nov;26(11):1595-1602. doi: 10.1158/1055-9965.EPI-17-0502. Epub 2017 Aug 22.
3
Plasma Circulating Cell-free DNA Integrity as a Promising Biomarker for Diagnosis and Surveillance in Patients with Hepatocellular Carcinoma.
口腔鳞状细胞癌与健康对照者循环肿瘤DNA水平的比较:一项病例对照研究。
BMC Oral Health. 2025 Jul 5;25(1):1101. doi: 10.1186/s12903-025-06403-6.
4
Applications for Circulating Cell-Free DNA in Oral Squamous Cell Carcinoma: A Non-Invasive Approach for Detecting Structural Variants, Fusions, and Oncoviruses.循环游离DNA在口腔鳞状细胞癌中的应用:一种检测结构变异、融合和肿瘤病毒的非侵入性方法。
Cancers (Basel). 2025 Jun 6;17(12):1901. doi: 10.3390/cancers17121901.
5
Mitochondrial D-loop variants and copy number alterations in saliva of basaloid squamous cell carcinoma patient: Can it be worth as a prognostic value? Case report.基底样鳞状细胞癌患者唾液中的线粒体D环变异和拷贝数改变:它是否具有预后价值?病例报告。
Int J Surg Case Rep. 2025 Jul;132:111440. doi: 10.1016/j.ijscr.2025.111440. Epub 2025 May 16.
6
Role of circulating tumor DNA and cell-free DNA biomarkers in diagnosis and prognosis of oral cancer - a systematic review.循环肿瘤DNA和游离DNA生物标志物在口腔癌诊断和预后中的作用——一项系统评价
BMC Oral Health. 2025 Apr 11;25(1):522. doi: 10.1186/s12903-025-05898-3.
7
5-Hydroxymethylcytosine signatures in circulating cell-free DNA as potential diagnostic markers for breast cancer.循环游离DNA中的5-羟甲基胞嘧啶特征作为乳腺癌的潜在诊断标志物
Biomark Med. 2025 May;19(9):317-328. doi: 10.1080/17520363.2025.2483156. Epub 2025 Mar 26.
8
Role of Cell-free DNA as a Non-Invasive Biomarker in the Detection of Head and Neck Squamous Cell Carcinoma.游离DNA作为非侵入性生物标志物在头颈部鳞状细胞癌检测中的作用
Indian J Clin Biochem. 2025 Apr;40(2):294-299. doi: 10.1007/s12291-024-01181-4. Epub 2024 Feb 5.
9
Unveiling the impact of corticosteroid therapy on liquid biopsy-detected cell-free DNA levels in meningioma and glioblastoma patients.揭示皮质类固醇疗法对脑膜瘤和胶质母细胞瘤患者液体活检检测到的游离DNA水平的影响。
J Liq Biopsy. 2024 Mar 20;5:100149. doi: 10.1016/j.jlb.2024.100149. eCollection 2024 Sep.
10
The Efficacy of Liquid Biopsy of Total cfDNA for Predicting Systemic Metastasis in Japanese Patients With Oral Squamous Cell Carcinoma.全游离DNA液体活检对日本口腔鳞状细胞癌患者全身转移的预测效能
Head Neck. 2025 May;47(5):1411-1420. doi: 10.1002/hed.28054. Epub 2024 Dec 27.
血浆循环游离DNA完整性作为肝细胞癌患者诊断和监测的一种有前景的生物标志物。
J Cancer. 2016 Aug 12;7(13):1798-1803. doi: 10.7150/jca.15618. eCollection 2016.
4
The development of a liquid biopsy for head and neck cancers.用于头颈癌的液体活检技术的发展。
Oral Oncol. 2016 Oct;61:8-11. doi: 10.1016/j.oraloncology.2016.07.014. Epub 2016 Aug 1.
5
Circulating tumor DNA detection in lung cancer patients before and after surgery.肺癌患者手术前后循环肿瘤 DNA 的检测。
Sci Rep. 2016 Sep 19;6:33519. doi: 10.1038/srep33519.
6
The Prognostic Value of Circulating Cell-Free DNA in Colorectal Cancer: A Meta-Analysis.循环游离DNA在结直肠癌中的预后价值:一项荟萃分析
J Cancer. 2016 Jun 4;7(9):1105-13. doi: 10.7150/jca.14801. eCollection 2016.
7
Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites.逆转录病毒整合位点的扩增、下一代测序及基因组DNA图谱分析
J Vis Exp. 2016 Mar 22(109):53840. doi: 10.3791/53840.
8
Assessment of the total cfDNA and HPV16/18 detection in plasma samples of head and neck squamous cell carcinoma patients.对头颈部鳞状细胞癌患者血浆样本中总游离DNA及人乳头瘤病毒16/18的检测评估。
Oral Oncol. 2016 Mar;54:36-41. doi: 10.1016/j.oraloncology.2015.12.002. Epub 2016 Jan 11.
9
Circulating DNA and Survival in Solid Tumors.循环DNA与实体瘤的生存
Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):399-406. doi: 10.1158/1055-9965.EPI-15-0893. Epub 2015 Nov 24.
10
Circulating free DNA concentration is an independent prognostic biomarker in lung cancer.循环游离 DNA 浓度是肺癌的独立预后生物标志物。
Eur Respir J. 2015 Dec;46(6):1773-80. doi: 10.1183/13993003.00676-2015. Epub 2015 Oct 22.